GLP-1 prescribing enters the GP contract
From April 2026 English GP practices earn QOF payments for tirzepatide prescribing, backed by ring-fenced funding. Weight-loss medicine is going mainstream, and it changes the private clinic’s job.
The news engine
Aesthetics regulation and industry news, explained.
Licensing scheme milestones, prescribing rules, safety alerts and qualification changes, tracked, dated and interpreted for practitioners by our faculty.
-
-
No, the aesthetics licence is not in force yet
Training adverts are claiming mandatory licensing arrived in spring 2026, or arrives in July. Neither is true. Here is the verifiable status in all four UK nations, and…
-
Liquid BBLs meet the enforcement summer
A court injunction against a BBL injector, an ASA enforcement push and a promised consultation on restricting high-risk procedures to healthcare professionals. The non-surgical BBL is where UK…
-
Aurelia opens 2026/27 intake with published ratios
Our new intake opens with the transparency standard we want the sector held to. Every clinical course page now publishes its trainer ratio, model access and honest limitations.
-
What the evidence says about polynucleotides
The fastest-growing regenerative treatment in UK clinics, reviewed honestly. Here are the mechanisms, the current evidence base and the consultation claims to avoid.
-
How to protect your course fees when a provider fails
A major academy’s collapse left students thousands out of pocket mid-qualification. Here is the due-diligence checklist, and how staged payments protect you, from our governance faculty.
-
The NMC face-to-face prescribing rule, one year on
Twelve months after the NMC banned remote prescribing for cosmetic medicines, the operational lessons are clear, and some business models haven’t caught up.
-
Weight-loss injection enforcement steps up again
MHRA, ASA and GPhC renewed their advertising enforcement notice in June 2026 after a year of factory raids, seizures and removed posts. The compliant-clinic advantage is now real.
-
What the 2025 botulism outbreak changed for injectors
41 iatrogenic botulism cases across five English regions, linked to unlicensed product, and the sourcing discipline every practitioner should be able to evidence.
-
Scotland’s cosmetic procedures Act passes, licences due September 2027
Scotland has done what England is still consulting on. The 2026 Act restricts higher-risk procedures to healthcare professionals in HIS-registered premises and brings council licensing for lower-risk treatments.
-
Red-tier consultation still missing from England’s cosmetic licence
The follow-up consultation on highest-risk procedures, promised for early then spring 2026, had not appeared by July. Here is where the scheme actually stands and what practitioners should…